Palisade Bio PALI Cash Flow Statement (2010-2026)

NASDAQ PALI
$1.43 +0.09 (+6.72%)
At close: Oct 20, 2026 · 4:00 PM EDT
Reported Financials

Palisade Bio Quarterly Cash Flow Statement

Periods 65 quarters
Latest Jun 2026

Palisade Bio reported cash from operations of -$7.60M and free cash flow of -$7.60M for the quarter ended Jun 2026, down 318.4% year over year. This cash flow statement covers 65 quarters of results from Jun 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
8.09M1.07M-4.21M-2.34M-3.99M-3.72M-2.34M-3.39M-3.60M-2.97M-3.53M-4.08M-3.49M-3.34M-2.23M-2.78M-2.87M-8.90M-9.60M-10.57M
Depreciation and DepletionDep. & Depletion
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
Depreciation & Amortization (CF)Dep. & Amort.
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Share-based CompensationStock Comp.
0.10M0.68M0.36M0.34M0.25M0.09M0.09M0.14M0.19M0.19M0.12M0.36M0.09M0.08M0.07M0.06M0.09M3.73M4.30M4.78M
Gains from Sales and DivestituresGains Divest
0.00M
Gains from Investment SecuritiesGains Investment
12.76M5.09M0.79M1.23M0.39M0.02M0.04M0.02M
Other non-cash itemsOther Non-Cash
0.05M0.05M0.02M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.11M0.02M
Change in Working Capital
Change in ReceivablesChange Receivables
-0.06M0.25M
Change in Accured ExpensesChange Accured Exp.
-0.01M-0.25M-0.44M0.00M1.14M-0.31M-0.97M0.60M0.18M-0.31M0.62M-0.11M0.02M0.29M-0.60M1.81M-0.96M0.37M2.56M-0.52M
Change in Other Operating AssetsOther Assets Change
-0.03M-0.11M-0.27M0.04M-0.52M-0.28M-0.28M-0.22M-0.10M-0.11M-0.17M-0.18M-0.19M-0.21M-0.07M0.09M0.52M-1.07M-0.02M0.94M
Change in Other Operating LiabilitiesOther Liabilities Change
-0.04M-0.05M-0.05M-0.05M-0.03M-0.02M-0.03M-0.03M-0.03M-0.03M-0.03M-0.03M-0.03M-0.03M-0.03M-0.03M-0.02M
Other Working Capital ChangesOther WC Changes
0.37M-0.38M0.22M-0.09M-0.02M0.25M0.19M0.15M0.15M0.04M-0.12M-0.54M0.02M-0.94M
Cash from OperationsCash from Ops.
-2.75M-3.06M-3.76M-3.25M-3.04M-3.31M-3.53M-2.20M-2.66M-2.75M-3.18M-3.50M-3.13M-2.38M-2.33M-1.82M-3.55M-3.14M-3.89M-7.60M
Investing Activities
Capital ExpendituresCapex
0.01M
Change in Property, Plant and EquipmentChange in PP&E
-0.01M
Change in IntangiblesChange Intangibless
Acquisitions
0.35M
Net of Acquisitions & DivestmentsNet Acquisitions
-0.35M
Purchase of InvestmentsInvestments Purchased
Sale and Maturity of InvestmentsInvestments Sold
Cash from Investing ActivitiesCash from Investing
-0.35M-0.01M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
Long-Term Debt RepaymentsLT Debt Repayment
Non-Current Debt
Short-Term Debt issuancesST Debt Issuance
Short-Term Debt repaymentsST Debt Repayment
0.66M0.48M0.09M0.17M0.26M0.27M0.09M0.05M0.15M0.10M0.16M0.11M0.16M0.08M0.10M0.14M0.07M
Current Debt
-0.66M-0.48M-0.09M-0.17M-0.26M-0.27M-0.09M-0.05M-0.15M-0.10M-0.16M-0.11M-0.16M-0.08M-0.10M-0.14M-0.07M
Net Debt Issuances and RepaymentsNet Debt Issuance
-0.66M-0.48M-0.09M-0.17M-0.26M-0.27M-0.09M-0.05M-0.15M-0.10M-0.16M-0.11M-0.16M-0.08M-0.10M-0.14M-0.07M
Change in Capital Stock
Common Stock IssuedStock Issued
0.10M1.78M12.63M2.27M4.94M5.50M1.74M0.02M2.50M4.01M4.44M0.00M3.91M131.96M3.25M0.18M
Net Shares Issued and RepurchasedNet Shares Issued
0.10M1.78M12.63M2.27M4.94M5.50M1.74M0.02M2.50M4.01M4.44M0.00M3.91M131.96M3.25M0.18M
Net Equity Issued and RepurchasedNet Equity Issued
0.10M1.78M12.63M2.27M4.94M5.50M1.74M0.02M2.50M4.01M4.44M0.00M3.91M131.96M3.25M0.18M
Other financing activitiesOther financing
0.03M-0.02M-0.32M-0.29M-0.41M-0.14M-0.02M-0.05M-0.41M-0.07M-0.12M-0.18M-0.44M-0.05M-0.03M
Cash from Financing ActivitiesCash from Financing
4.55M-0.55M-0.09M1.59M12.05M1.71M4.44M5.31M1.57M-0.13M2.02M3.58M-0.18M4.16M-0.26M0.00M3.36M131.33M3.13M0.15M
Additional items
Exchange Rate EffectFX Effect
Change in Cash
1.45M-3.61M-3.85M-1.66M9.01M-1.60M0.91M3.11M-1.09M-2.88M-1.16M0.08M-3.31M1.78M-2.59M-1.81M-0.19M128.19M-0.76M-7.46M
Ending Cash Balance
14.13M10.52M6.67M12.41M12.46M9.85M133.44M
Free Cash FlowFCF
-2.75M-3.06M-3.76M-3.25M-3.04M-3.32M-3.53M-2.20M-2.66M-2.75M-3.18M-3.50M-3.13M-2.38M-2.33M-1.82M-3.55M-3.14M-3.89M-7.60M
Net Cash FlowNCF
1.45M-3.61M-3.85M-1.66M9.01M-1.60M0.91M3.11M-1.09M-2.88M-1.16M0.08M-3.31M1.78M-2.59M-1.81M-0.19M128.19M-0.76M-7.46M
Interest Paid
0.01M0.00M0.01M0.01M0.00M0.00M0.01M0.00M0.00M0.01M0.01M0.00M0.00M0.01M0.00M

Palisade Bio Cash Flow Statement API

Pull Palisade Bio's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=PALI&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY